News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
310,913 Results
Type
Article (11202)
Company Profile (63)
Press Release (299648)
Multimedia
Podcasts (11)
Webinars (5)
Section
Business (99987)
Career Advice (690)
Deals (17867)
Drug Delivery (15)
Drug Development (30990)
Employer Resources (40)
FDA (6773)
Job Trends (6387)
News (156264)
Policy (11117)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (813)
Accelerated approval (16)
Adcomms (5)
Allergies (115)
Alliances (20801)
ALS (71)
Alzheimer's disease (590)
Antibody-drug conjugate (ADC) (106)
Approvals (7077)
Artificial intelligence (216)
Autoimmune disease (65)
Automation (17)
Bankruptcy (115)
Best Places to Work (5222)
BIOSECURE Act (2)
Biosimilars (67)
Biotechnology (58)
Bladder cancer (80)
Brain cancer (21)
Breast cancer (296)
Cancer (2010)
Cardiovascular disease (122)
Career advice (596)
Career pathing (12)
CAR-T (105)
CDC (4)
Cell therapy (286)
Cervical cancer (10)
Clinical research (27112)
Collaboration (729)
Compensation (449)
Complete response letters (17)
COVID-19 (836)
CRISPR (26)
C-suite (479)
Cystic fibrosis (58)
Data (2781)
Denatured (3)
Depression (44)
Diabetes (154)
Diagnostics (3046)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (18)
Drug discovery (135)
Drug pricing (24)
Drug shortages (6)
Duchenne muscular dystrophy (80)
Earnings (47023)
Editorial (10)
Employer branding (6)
Employer resources (42)
Events (50384)
Executive appointments (584)
FDA (8155)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (622)
Gene editing (55)
Generative AI (22)
Gene therapy (178)
GLP-1 (259)
Government (1027)
Grass and pollen (4)
Guidances (233)
Healthcare (6897)
HIV (23)
Huntington's disease (17)
IgA nephropathy (40)
Immunology and inflammation (78)
Immuno-oncology (16)
Indications (56)
Infectious disease (909)
Inflammatory bowel disease (83)
Inflation Reduction Act (3)
Influenza (32)
Intellectual property (62)
Interviews (86)
IPO (9060)
IRA (6)
Job creations (1404)
Job search strategy (536)
JPM (11)
Kidney cancer (12)
Labor market (15)
Layoffs (142)
Leadership (8)
Legal (2934)
Liver cancer (32)
Longevity (7)
Lung cancer (225)
Lymphoma (178)
Machine learning (18)
Management (14)
Manufacturing (230)
MASH (60)
Medical device (4695)
Medtech (4709)
Mergers & acquisitions (9384)
Metabolic disorders (375)
Multiple sclerosis (66)
NASH (8)
Neurodegenerative disease (132)
Neuropsychiatric disorders (22)
Neuroscience (1113)
NextGen: Class of 2026 (2237)
Non-profit (1186)
Now hiring (17)
Obesity (159)
Opinion (71)
Ovarian cancer (64)
Pain (52)
Pancreatic cancer (76)
Parkinson's disease (117)
Partnered (16)
Patents (101)
Patient recruitment (167)
Peanut (57)
People (32347)
Pharmaceutical (14)
Pharmacy benefit managers (4)
Phase 1 (7817)
Phase 2 (11198)
Phase 3 (9990)
Pipeline (2852)
Policy (43)
Postmarket research (1174)
Preclinical (3349)
Press Release (69)
Prostate cancer (109)
Psychedelics (11)
Radiopharmaceuticals (142)
Rare diseases (329)
Real estate (2346)
Recruiting (10)
Regulatory (8773)
Reports (21)
Research institute (851)
Resumes & cover letters (91)
Rett syndrome (25)
RNA editing (7)
RSV (12)
Schizophrenia (76)
Series A (111)
Series B (84)
Service/supplier (2)
Sickle cell disease (35)
Special edition (2)
Spinal muscular atrophy (64)
Sponsored (11)
Startups (1536)
State (1)
Stomach cancer (3)
Supply chain (30)
Tariffs (11)
The Weekly (8)
Vaccines (251)
Venture capital (24)
Weight loss (77)
Women's health (19)
Worklife (3)
Date
Today (17)
Last 7 days (246)
Last 30 days (855)
Last 365 days (13691)
2026 (1543)
2025 (13836)
2024 (16336)
2023 (19053)
2022 (25523)
2021 (27303)
2020 (24467)
2019 (18269)
2018 (13841)
2017 (13862)
2016 (12854)
2015 (16263)
2014 (12488)
2013 (9951)
2012 (10657)
2011 (11230)
2010 (10678)
Location
Africa (277)
Alabama (38)
Alaska (3)
Arizona (107)
Arkansas (1)
Asia (15858)
Australia (2313)
California (5435)
Canada (1932)
China (306)
Colorado (175)
Connecticut (216)
Delaware (164)
Europe (35909)
Florida (683)
Georgia (111)
Hawaii (3)
Idaho (28)
Illinois (284)
India (31)
Indiana (231)
Iowa (11)
Japan (256)
Kansas (44)
Kentucky (21)
Louisiana (11)
Maine (54)
Maryland (522)
Massachusetts (4120)
Michigan (160)
Minnesota (256)
Mississippi (2)
Missouri (51)
Montana (21)
Nebraska (16)
Nevada (62)
New Hampshire (29)
New Jersey (1782)
New Mexico (11)
New York (1295)
North Carolina (667)
North Dakota (6)
Northern California (2740)
Ohio (156)
Oklahoma (11)
Oregon (16)
Pennsylvania (887)
Puerto Rico (7)
Rhode Island (22)
South America (416)
South Carolina (19)
Southern California (2106)
Tennessee (84)
Texas (735)
United States (18654)
Utah (156)
Virginia (112)
Washington D.C. (29)
Washington State (423)
West Virginia (3)
Wisconsin (80)
Wyoming (2)
310,913 Results for "reaction biology corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fresenius Kabi and Phlow Corp. Announce First-Ever, End-to-End, U.S. Manufacturing Collaboration for Epinephrine Injection, USP
February 10, 2026
·
7 min read
Press Releases
neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)
December 29, 2025
·
11 min read
Press Releases
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
February 2, 2026
·
9 min read
Press Releases
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
February 12, 2026
·
1 min read
Press Releases
Profound Medical Corp. Announces Closing of Private Placement
December 30, 2025
·
5 min read
Press Releases
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
January 21, 2026
·
7 min read
Press Releases
Scryb Inc. Provides Early Warning Update on Holdings in Cybeats Technologies Corp.
January 15, 2026
·
5 min read
Press Releases
Renmark Financial Communications to Host TRX Gold Corp. in Virtual Non-Deal Roadshow Series on Thursday, February 19, 2026
February 12, 2026
·
2 min read
Press Releases
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
January 23, 2026
·
6 min read
Press Releases
ARS Pharma Launches Get neffy® on Us for Patients with Severe Allergic Reactions to Improve Access to neffy (epinephrine nasal spray)
November 5, 2025
·
8 min read
1 of 31,092
Next
